Navigation Links
CBI Announces 13th Annual Patient Assistance and Access Programs
Date:1/9/2012

WOBURN, Mass., Jan. 9, 2012 /PRNewswire/ -- Advanstar|CBI recently announced the full agenda for their 13th Annual Patient Assistance and Access Programs. The Forum takes place March 6-7, 2012 in Baltimore, MD.

PAP's speaker faculty includes leading experts from Eli Lilly, Genentech, AstraZeneca, Shire Human Genetic Therapies and many more.

Patient Assistance Pavilion participant Needy Meds recently interviewed PAP's Senior Program Manager, Sharon Langan. During the interview, Langan delved into the details of the conference, including new speakers and highlights from the agenda, notably, a new Safety Net Resources Track, chaired by Needy Meds.

This Forum is the most robust and renowned meeting for executives engaged in pharmaceutical patient assistance and access programs. For more information on the conference or to view the entire agenda, please visit http://www.cbinet.com/pap.

About CBI:

CBI, a subsidiary of Advanstar, is the leading provider of market-driven, unbiased conferences for the pharmaceutical, biotechnology, medical device and healthcare industries. CBI offers specialized information presented in interactive formats by thought leaders and regulators. CBI's conferences provide a unique platform for concrete, real-life examples that can be applied to any organization immediately, significantly impacting both costs and revenue. For more information, please visit http://www.cbinet.com.

For additional information or media inquiries, please contact Kristina Weljkovic, Marketing Manager, at 339-298-2285.

 

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE CBI
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Veracyte Announces Medicare Coverage for Its Afirma® Gene Expression Classifier for Improved Thyroid Nodule Diagnosis
2. diaDexus, Inc. Pre-Announces 2011 Q4, YE Revenue and 2012 Guidance
3. SFJ Pharma Ltd. II, Announces Agreement With Pfizer to Develop Axitinib for Adjuvant Treatment of Renal Cell Carcinoma
4. Sequenom Announces 2011 Operational Highlights and Early 2012 Outlook
5. Sutro Announces Newly Formed Scientific Advisory Board
6. AnaptysBio Announces New Strategic Antibody Discovery
7. Tengion Announces Relocation of Corporate Headquarters to Current Facility in Winston-Salem, North Carolina
8. Sangamo BioSciences Announces Presentation at J.P. Morgan Healthcare Conference
9. AtheroNova Announces a New Board Member
10. RSB Spine, LLC Announces 2011 Revenue Growth
11. ThermoGenesis Announces Approval of AXP® by India Ministry of Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2013)... Significant research in quantum optics, metamaterials and ... presentation of awards by the International Commission for ... during the SPIE Optics and Optoelectronics 2013 symposium in ... photonics , is an International Society Member of the ... with the 2011 ICO Galileo Galilei Award, for his ...
(Date:5/25/2013)... Dennis R. HIll M.D. Radiation Oncologist at the ... recently there has been a promotion of the idea that ... seed, or low dose rate, brachytherapy for prostate cancer. The ... a shorter half life, and gives a higher biologically effective ... has a higher average energy than the other commonly used ...
(Date:5/24/2013)... Swedesboro, NJ (PRWEB) May 24, 2013 Dr. ... Elmer, NJ and Swedesboro, NJ, are proud to announce an ... event will take place on Saturday, June 8th from 10 ... Dr. Warmuth, Anamaria Newport, MHS, PA-C and staff will be ... dermal fillers, laser and aesthetic treatments, and provide complimentary cosmetic ...
(Date:5/24/2013)... In a sneak preview of the ... technologies with applications in multiple and diverse areas ... and Photonics symposium in San Diego, California, ... society for optics and photonics , the event ... technology meeting in North America, with approximately 4,500 ...
Breaking Biology Technology:ICO Honors Three with Awards during SPIE Optics and Optoelectronics 2ICO Honors Three with Awards during SPIE Optics and Optoelectronics 3Dennis R. Hill MD HDR Prostate Brachytherapy Specialist Compares Prostate Cancer Treatment Options: Not All Low Dose Rate Brachytherapy Isotopes Are the Same 2Dennis R. Hill MD HDR Prostate Brachytherapy Specialist Compares Prostate Cancer Treatment Options: Not All Low Dose Rate Brachytherapy Isotopes Are the Same 3See What’s in Earth’s Future ? and Out in Space Now ? at SPIE Optics and Photonics 2See What’s in Earth’s Future ? and Out in Space Now ? at SPIE Optics and Photonics 3See What’s in Earth’s Future ? and Out in Space Now ? at SPIE Optics and Photonics 4
... up to ... $385 million plus royalties -, PALO ALTO, ... announced today that it has entered into an agreement,granting exclusive ... countries to the Menarini Group. Menarini,with its significant pan-European presence, ...
... Management,Slate of InSite Vision, Including the Chairman and ... Sept. 11 PTV Sciences,("PTV"), a healthcare venture ... that RiskMetrics Group -(Formerly known as ISS), the ... that the,stockholders of InSite Vision Incorporated (Amex: ...
... 11 A project to advance,research and improve ... by a,new $1.6 million, three-year cooperative agreement with ... The agreement, intended to bring better care to ... National Fragile X Foundation (NFXF),the CDC,s National Center ...
Cached Biology Technology:CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group 2CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group 3CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group 4CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group 5RiskMetrics (ISS), An Independent Proxy Advisory Firm, Recommends Voting the GOLD Card for Four of PTV's Nominees: Anderson, McInerney, Melrose, and O'Holla 2RiskMetrics (ISS), An Independent Proxy Advisory Firm, Recommends Voting the GOLD Card for Four of PTV's Nominees: Anderson, McInerney, Melrose, and O'Holla 3RiskMetrics (ISS), An Independent Proxy Advisory Firm, Recommends Voting the GOLD Card for Four of PTV's Nominees: Anderson, McInerney, Melrose, and O'Holla 4$1.6 Million Agreement to Accelerate Fragile X Research, Inspire Hope 2
(Date:5/24/2013)... combat metastatic cancer , Cancer cells spread and ... system. Stimulation of the immune system can help to ... cause the immune system to ignore cancer cells. Regulatory ... the immune system response. In this issue of the ... Ronald Levy at Stanford University found that regulatory T ...
(Date:5/24/2013)... against Alzheimer,s disease, scientists have focused among other factors ... After all, it is the accumulation of A-beta that causes ... point for the formation of A-beta is APP. Alessia Soldano ... the function of APPL the fruit-fly version of APP ... Alessia Soldano (VIB/KU Leuven): "We have discovered that APPL ensures ...
(Date:5/23/2013)... National Laboratory honored more than 165 staff for ... at PNNL,s annual Intellectual Property Commercialization Recognition & ... Energy national laboratory named materials scientist Jun Liu ... battery materials that can store large amounts of ... reduce the time it takes to charge cell ...
Breaking Biology News(10 mins):JCI early table of contents for May 24, 2013 2JCI early table of contents for May 24, 2013 3JCI early table of contents for May 24, 2013 4JCI early table of contents for May 24, 2013 5JCI early table of contents for May 24, 2013 6JCI early table of contents for May 24, 2013 7JCI early table of contents for May 24, 2013 8A new strategy required in the search for Alzheimer's drugs? 2PNNL staff recognized for scientific accomplishments, moving technologies into the marketplace 2
... , DNA-Prokids ( http://www.dna-prokids.org ), an international project ... victims and their relatives, was officially presented today, at the ... Traffic in human beings is one of the most ... century. According to data from the United Nations Office on ...
... rapid growth of institutional Memberships for open access ... of the "Online Reporting System" for its open ... BioMed Central,s cutting edge publishing platform, the new ... and help reduce the administrative costs associated with ...
... Stedim Biotech (SSB) and Adolf Kühner AG ,- Prototype ... ,Monthey, 19. Mai 2009 / b3c newswire ... to the biopharmaceutical industry, expands its product offering with ... OrbShake bioreactors rely on orbital shaking principles for ...
Cached Biology News:DNA-Prokids: Genetic identification against traffic in human beings 2ExcellGene SA first company to offer contract manufacturing in 250 Liter OrbShake bioreactor 2ExcellGene SA first company to offer contract manufacturing in 250 Liter OrbShake bioreactor 3
... Clone/PAD: ZMD.460. Immunogen: Synthetic ... the human C35 protein (chromosome 17 open ... Specificity: Specific for the C35 protein. ... band at ~15 kDa band. Reactivity: ...
...
... Peptide sequences: Two ... peptide corresponding to the same sequence ... polyclonal antiserum (Catalog No. 160890) ... conjunction with Cayman's guanylate cyclase polyclonal ...
... Calmodulin Sepharose ... For single-step purification ... fusion proteins.Purification of ... all eukaryotic cells. ...
Biology Products: